HB 1914 updates fees for Washington State Parks' Discover Pass and day-use permits, raising the annual Discover Pass from $30 to $45 and day-use permits from $10 to $15. It requires the Office of Financial Management to review and adjust these fees every four years to account for inflation, ensuring they keep pace with rising costs of maintaining parks. The bill directly affects all visitors and residents using Washington's state parks by vehicle or for day visits. These changes implement the original 2011 law's provision for periodic fee adjustments due to inflation.
SB 5768 expands Washington State's Working Families Tax Credit to include all low-income residents aged 18 and older, removing previous age restrictions. It affects Washington residents who file federal tax returns, pay state sales/use tax, and meet income limits (e.g., $300 for those with no children, up to $1,200 for those with three+ children). The bill maintains existing credit amounts, phase-out rules based on income, and inflation adjustments, while adding a new eligibility category for those aged 18+ who otherwise qualify under federal tax code rules. This change directly broadens access to the refundable credit for younger adults who previously may have been excluded due to age.
HB 1062 requires all health plans in Washington (including commercial plans, public employee coverage, and state Medicaid) to cover biomarker testing starting January 1, 2026. This applies to tests that measure biological markers in tissue or blood (like gene mutations) when used for diagnosis, treatment, or monitoring of a patient’s condition, provided the test is supported by FDA approvals, Medicare guidelines, clinical practice standards, or expert consensus. Plans must ensure coverage without causing unnecessary disruptions, such as requiring multiple biopsies. The bill mandates this coverage uniformly across all plan types under specific evidence-based criteria.
SB 5257 modifies sentencing standards for juveniles under 18 charged with possessing firearms. It changes the offense classification from "B+" to "C+" in Washington's juvenile sentencing grid for this specific violation. This adjustment reduces the potential sentence range from 15-36 weeks (for B+ offenses) to 15-36 weeks (for C+ offenses), though the exact range remains similar. The bill directly affects minors aged 15-17 who face firearm possession charges, altering how courts determine sentencing severity. The change applies to RCW 9.41.040(2)(a)(v), which covers firearm possession by minors under 18.
HB 1229 allows individuals sentenced as persistent offenders or receiving exceptional sentences (to avoid persistent offender status) due to a second-degree robbery conviction to seek resentencing. It requires public defense offices to review cases where second-degree robbery was used to establish persistent offender status or as part of a plea agreement, and to file motions for resentencing if eligible. The bill mandates courts to resentence these individuals as if second-degree robbery was not the "most serious offense" at sentencing, effectively removing it from consideration in sentencing calculations. This policy change applies to both current sentences and future cases after July 2021, ensuring second-degree robbery no longer qualifies as a "most serious offense" for persistent offender sentencing.
This bill (SB 5765) primarily redefines terms related to psychiatric care and behavioral health services in Washington State law, including terms like "psychiatric pharmacists," "antipsychotic medications," and "behavioral health service provider." It amends existing definitions within statutes governing mental health and substance use disorder services but does not establish new duties or requirements for pharmacists. The bill focuses on clarifying terminology for consistency across related laws, with no concrete policy changes described in the provided text. It is a definitional amendment, not a substantive policy change affecting practice or services.
SB 5687 increases the portion of Washington's general sales tax revenue dedicated to performance audits from 0.16% to 0.2%. This change applies to taxes collected under RCW 82.08.020(1) on retail sales of tangible goods, digital products, and certain services. The additional funds must be deposited into the "performance audits of government account" established under RCW 43.09.475. The law takes effect January 1, 2026, and directly affects all businesses collecting retail sales tax in Washington.
SB 5318 requires fingerprint-based background checks for individuals seeking certain jobs involving unsupervised access to vulnerable adults, children, or juveniles in Washington state. It affects long-term care workers, child placement providers, residential facility staff, and others in roles covered by specific state agencies (like DHS and DCS), particularly when applicants have lived in Washington less than three consecutive years. The bill mandates submitting fingerprints to both the Washington State Patrol and FBI for background checks to verify character and suitability for these positions.
HB 1277 creates a tax exemption for critical access hospitals located on islands within 25 miles of a military installation, eliminating sales and use taxes on qualifying medical equipment (like diagnostic machines) and supplies (such as gloves, syringes, and bandages). The exemption applies to purchases and use of these items beginning January 1, 2026, and expires January 1, 2036. It excludes construction materials, office equipment, and non-medical vehicles. This policy directly affects designated island-based hospitals by reducing their operational costs for essential medical resources.
HB 1725 requires health plans in Washington to streamline access to biosimilar medicines (safe, effective, lower-cost alternatives to brand-name biologics) by mandating clear exception processes for coverage denials. It directly affects patients, doctors, and health insurance companies by requiring health plans to: (1) post plain-language exception rules online, (2) approve exceptions meeting specific medical criteria (like drug ineffectiveness or adverse reactions), and (3) follow strict timelines (1-3 business days) for urgent/non-urgent requests. The bill eliminates barriers by ensuring health plans must cover biosimilars when clinical evidence supports them, with automatic approval if deadlines are missed. This aims to reduce prescription drug costs without altering drug approval standards.
House Bill 2078 seeks to expand access to medical cannabis and related services in Washington state. The bill allows licensed cannabis processors to obtain a medical cannabis endorsement, enabling them to sell Department of Health-compliant cannabis products directly to qualifying patients and their designated providers. This endorsement also permits both cannabis retailers and processors to provide cannabis at no charge to these individuals. Overall, the bill aims to increase the availability of medical cannabis options for registered patients.
SB 5591 creates a local sales and use tax reimbursement program for developers building affordable housing projects. It allows cities or counties to adopt programs that reimburse developers for sales taxes paid on construction materials, provided the project includes at least 50% units affordable to low-income households (costing ≤30-38% of income) for 40 years. Developers must apply to local governments, meet strict affordability and timeline requirements (completion within 3 years), and maintain affordability for the full 40-year period. The program applies only to projects meeting Washington’s defined "affordable housing" standards and requires local government approval before implementation.
